AgomAb Therapeutics NV (AGMB)
12.14
+0.06
(+0.50%)
USD |
NASDAQ |
Sep 18, 16:00
12.14
0.00 (0.00%)
After-Hours: 18:40
AgomAb Therapeutics Shareholders Equity (Quarterly) : 153.74M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 153.74M |
| Date | Value |
|---|---|
| December 31, 2024 | 194.76M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 1.044M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| GB Sciences, Inc. | -- |
| Invion Ltd. | -- |
| Arvinas, Inc. | 562.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 180.52M |
| Total Liabilities (Quarterly) | 26.78M |
| Debt to Equity Ratio | 0.0096 |
| Current Ratio | 6.488 |